Convergence of biomaterials and immunology: a technology platform for delayed burst release of vaccines. A large challenge in vaccination, particularly in wildlife such as for the growing problem of Chlamydia in koalas, is to provide the necessary booster shots. This project will develop implants that will be inserted under the skin at the time of the first shot, and will spontaneously burst later to release the booster shot to provide protection.
Linkage Infrastructure, Equipment And Facilities - Grant ID: LE0775684
Funder
Australian Research Council
Funding Amount
$230,000.00
Summary
The polymer pharmaceutical/drug characterization and processing facility. The Australian population is ageing, and this is leading to ever increasing burdens upon our health system. In addition new understanding of disease states has lead to a demand for improved materials for drug delivery and for tissue regeneration. This proposal will lead to novel biomaterials designed to meet these demands. Polymers are seen as essential elements for construction of such biomedical devices due to the myriad ....The polymer pharmaceutical/drug characterization and processing facility. The Australian population is ageing, and this is leading to ever increasing burdens upon our health system. In addition new understanding of disease states has lead to a demand for improved materials for drug delivery and for tissue regeneration. This proposal will lead to novel biomaterials designed to meet these demands. Polymers are seen as essential elements for construction of such biomedical devices due to the myriad forms in which they can be made, and the large number of different materials to choose from. This proposal will lead to the formation of the PolyPharma network which will produce polymeric biomaterials to benefit our health industries.Read moreRead less
Special Research Initiatives - Grant ID: SR0354797
Funder
Australian Research Council
Funding Amount
$20,000.00
Summary
The Australian Tissue Engineering Network. Driven by four key nodes across the country, the Initiative aims to bring together geographically and financially separated groups into a critical mass of cell and tissue engineering research. This new and rapidly-growing field uses a bio-synthetic approach to replace, repair or regenerate damaged tissues and organs. The Initiative will build the framework which will enable the Network to: identify appropriate expertise, manage duplication, enhance co ....The Australian Tissue Engineering Network. Driven by four key nodes across the country, the Initiative aims to bring together geographically and financially separated groups into a critical mass of cell and tissue engineering research. This new and rapidly-growing field uses a bio-synthetic approach to replace, repair or regenerate damaged tissues and organs. The Initiative will build the framework which will enable the Network to: identify appropriate expertise, manage duplication, enhance communication, bring together innovative skill sets, create linkages, generate focussed research programs and foster novel commercial opportunities. Ultimately the Initiative and Network will deliver an improved quality of life, reduced healthcare costs, and increased productivity to Australia.Read moreRead less
Novel manufacturing methods for tissue engineering scaffolds. Novel methods of manufacturing biodegradable polymer scaffolds around which new tissue can be grown within the human body will be developed. Surfactant - polymer assemblies will be used to produce highly porous scaffolds of tunable pore size and connectivity, shape and strength. The results will create a new avenue for systematic investigations into the effects of scaffold structure on tissue growth. This research will lead to the dev ....Novel manufacturing methods for tissue engineering scaffolds. Novel methods of manufacturing biodegradable polymer scaffolds around which new tissue can be grown within the human body will be developed. Surfactant - polymer assemblies will be used to produce highly porous scaffolds of tunable pore size and connectivity, shape and strength. The results will create a new avenue for systematic investigations into the effects of scaffold structure on tissue growth. This research will lead to the development of reliable, well-controlled manufacturing techniques for tissue engineering scaffolds, revolutionising current scaffold manufacturing practices. It will enhance existing collaborations between the University of Melbourne and the Bernard O'Brien Institute of Microsurgery.Read moreRead less
Mastering the Microenvironment - Integrated, functional, biosynthetic scaffolds for tissue engineering. Organ transplantation is available to only the lucky few, with, for example, less than 3000 of Australia's annual 30,000 patients suffering end-stage renal failure receiving transplants. Tissue engineering of soft, functional tissues using in vitro and/or in vivo methods offers the potential to replace missing or non-functioning tissues, such as liver, pancreas, lung, heart, fat and muscle, wi ....Mastering the Microenvironment - Integrated, functional, biosynthetic scaffolds for tissue engineering. Organ transplantation is available to only the lucky few, with, for example, less than 3000 of Australia's annual 30,000 patients suffering end-stage renal failure receiving transplants. Tissue engineering of soft, functional tissues using in vitro and/or in vivo methods offers the potential to replace missing or non-functioning tissues, such as liver, pancreas, lung, heart, fat and muscle, with newly created tissue. This project will deliver integrated, functional polymeric scaffolds for organ replacement. Over 12 higher degree candidates and one research associate will be trained in the field of tissue engineering, representing a significant benefit to the Australian scientific community.Read moreRead less
Scalable, high throughput microfluidic platforms for tissue specific biomaterials development and tissue genesis. The co-development of novel biomaterial platforms and new generation production methods for tissue analogues will provide the necessary stimulus for improved and more relevant methods of enhanced repair or regeneration of diseased or damaged tissues. These outcomes will result in faster time-to-market new generation therapeutic products for Australia and the world. These advances wil ....Scalable, high throughput microfluidic platforms for tissue specific biomaterials development and tissue genesis. The co-development of novel biomaterial platforms and new generation production methods for tissue analogues will provide the necessary stimulus for improved and more relevant methods of enhanced repair or regeneration of diseased or damaged tissues. These outcomes will result in faster time-to-market new generation therapeutic products for Australia and the world. These advances will have a significant impact on our healthcare costs and the quality of life for all Australians.Read moreRead less